Sekpharma (Pty) Ltd provides affordable, quality healthcare products to its target markets. Key brands include the leading injectible antibiotic Fortum and the well-established dermatological products Dermovate, Betnovate and Eumovate.

Sekpharma continues to focus on its traditional portfolio of owned dossiers. In its strategy of partnering with other relevant drugs, Sekpharma entered the wound treatment sector promoting an internationally accepted and respected natural product, “MEBO”, manufactured by Julphar Pharmaceuticals in the United Arab Emirates.

The main focus is to grow the business in two areas, these being prescription drugs (both originator and generic medication) and through the launch of a new consumer division in partnership with Julphar.